# First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects

> **NCT03103451** · PHASE1 · COMPLETED · sponsor: **Biocad** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BCD-121
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03103451
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03103451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03103451, "First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03103451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*